US 8759314
Methods for treating multiple sclerosis using antisense oligonucleotides
granted A61PA61P25/00A61P25/28
Quick answer
US patent 8759314 (Methods for treating multiple sclerosis using antisense oligonucleotides) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue Jun 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 31
- CPC classes
- A61P, A61P25/00, A61P25/28, A61P37/06, A61P43/00